March 23 (Reuters) - Medclair Invest AB MCLR.NGM :
* AMBITION TO BUY NOSEOPTION AB
* ACQUISITION IS EXPECTED TO AFFECT CO'S STRONG CASH
MARGINALLY
* ACQUISITION PRICE AMOUNTS TO ABOUT SEK 57 MILLION, WHICH
IS PAID
THROUGH A NON-CASH ISSUE OF MAXIMUM OF 32.5 MLN SHARES TO
SELLERS WITH SUBSCRIPTION PRICE OF SEK 1.75
* THROUGH ACQUISITION FORMER SHAREHOLDERS IN NOSA WILL OWN
ABOUT
30% OF MCI
Source text for Eikon: [ID:nBQNt2Ghr, nBQNbWC3Gs]
Further company coverage: MCLR.NGM
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))